Stockscreener 앱 받기
6.32
3.28%
0.19
전일 마감가:
$6.13
열려 있는:
$6.18
하루 거래량:
230.22K
Relative Volume:
0.62
시가총액:
$396.84M
수익:
$198.53M
순이익/손실:
$-63.68M
주가수익비율:
-6.1827
EPS:
-1.0222
순현금흐름:
$-41.50M
1주 성능:
+12.85%
1개월 성능:
+5.51%
6개월 성능:
-36.69%
1년 성능:
+9.34%
1일 변동 폭
$5.845
$6.34
1주일 범위
$5.17
$6.82
52주 변동 폭
$4.54
$10.79
트리스 메디컬 컨셉트 Stock (TMCI) Company Profile
명칭
Treace Medical Concepts Inc
전화
(904) 373-5940
주소
100 PALMETTO PARK PLACE, PONTE VEDRA
TMCI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TMCI
Treace Medical Concepts Inc
|
6.31 | 345.56M | 198.53M | -63.68M | -41.50M | -1.0222 |
|
ABT
Abbott Laboratories
|
131.32 | 227.88B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.92 | 152.55B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
377.10 | 143.34B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.64 | 114.49B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.22 | 46.15B | 5.69B | 4.14B | 577.90M | 6.96 |
트리스 메디컬 컨셉트 Stock (TMCI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-04 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2024-12-31 | 개시 | Lake Street | Buy |
| 2024-12-17 | 재개 | JP Morgan | Neutral |
| 2024-05-16 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-05-08 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2024-05-08 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-05-08 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-05-08 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-05-08 | 다운그레이드 | Truist | Buy → Hold |
| 2023-09-29 | 개시 | UBS | Buy |
| 2023-05-01 | 개시 | Truist | Buy |
| 2023-04-11 | 개시 | Stephens | Equal-Weight |
| 2022-05-12 | 개시 | BTIG Research | Buy |
| 2022-01-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-18 | 개시 | JP Morgan | Overweight |
| 2021-05-18 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-05-18 | 개시 | SVB Leerink | Outperform |
| 2021-05-18 | 개시 | Stifel | Buy |
모두보기
트리스 메디컬 컨셉트 주식(TMCI)의 최신 뉴스
Analysts Have Been Trimming Their Treace Medical Concepts, Inc. (NASDAQ:TMCI) Price Target After Its Latest Report - Yahoo Finance
Insider Stock Buying Reaches US$1.80m On Treace Medical Concepts - 富途牛牛
UBS Group Cuts Treace Medical Concepts (NASDAQ:TMCI) Price Target to $6.50 - MarketBeat
209,972 Shares in Treace Medical Concepts, Inc. (NASDAQ:TMCI) Bought by Arcadia Wealth Management Inc. - MarketBeat
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Just Reported, And Analysts Assigned A US$8.35 Price Target - simplywall.st
Treace Medical anticipates 7–10% revenue growth in 2025 while launching next-gen bunion solutions - MSN
Why did TMCI's Q4 2024 EPS surprise investors? - AInvest
Health Check: How Prudently Does Treace Medical Concepts (NASDAQ:TMCI) Use Debt? - simplywall.st
Stifel Nicolaus Lowers Treace Medical Concepts (NASDAQ:TMCI) Price Target to $6.00 - MarketBeat
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q2 2025 Earnings Call Transcript - Insider Monkey
Treace Medical Concepts Maintains Buy Rating with $12 Price Target: Analyst - AInvest
Treace Medical Concepts Inc (TMCI) Q2 2025 Earnings Call Highlights: Revenue Growth and ... By GuruFocus - Investing.com Canada
Treace Medical Concepts revenue up 7% to USD 47.4M in Q2 2025 - Medical Buyer
Treace Medical Concepts Reports Q2 2025 Financial Results - TipRanks
Treace Medical Concepts Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Treace Medical (TMCI) Q2 Revenue Up 7% - The Motley Fool
Treace Medical Concepts Trims Losses As Revenue Rises - Finimize
Treace Medical Concepts, Inc. shares rise 3.35% after-hours after Q2 revenue beats estimates. - AInvest
Treace Medical Concepts: Q2 Earnings Snapshot - San Antonio Express-News
Treace Medical Concepts (TMCI) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Treace Medical Concepts Reports Second Quarter 2025 Financial Results - The Manila Times
Treace Medical to Host Investor Day Highlighting New Products on September 3, 2025 - Yahoo Finance
Important Notice to Long-Term Shareholders of Centene - GlobeNewswire
Treace Announces Peer-Reviewed Publication of Four-Year Results of the ALIGN3D™ Lapiplasty® Multicenter Prospective Clinical Study - The Manila Times
Revolutionary Bunion Surgery Success: New 4-Year Study Reveals 99.2% Non-Recurrence Rate for Lapiplasty - Stock Titan
GSA Capital Partners LLP Buys Shares of 66,790 Treace Medical Concepts, Inc. (NASDAQ:TMCI) - MarketBeat
Analyzing Treace Medical Concepts Inc. with risk reward ratio chartsStock Market Watch with Smart Filters - Newser
Is Treace Medical Concepts Inc. stock ready for a breakoutRSI and MACD Signal Summary with Trends - Newser
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives $10.52 Average PT from Analysts - MarketBeat
How to interpret RSI for Treace Medical Concepts Inc. stockConservative Equity Setup with Signal Analysis - Newser
What catalysts could drive Treace Medical Concepts Inc. stock higher in 2025Invest like a pro with expert recommendations - Jammu Links News
What drives Treace Medical Concepts Inc. stock priceUnlock powerful trading techniques - Jammu Links News
What is the risk reward ratio of investing in Treace Medical Concepts Inc. stockUnmatched market performance - Jammu Links News
How many analysts rate Treace Medical Concepts Inc. as a “Buy”Exceptional profit potential - Jammu Links News
Is Treace Medical Concepts Inc. a growth stock or a value stockFree Risk Assessment Services - Jammu Links News
Does Treace Medical Concepts Inc. stock perform well during market downturnsAchieve breakthrough performance with smart picks - Jammu Links News
Treace Medical Concepts (TMCI) to Release Earnings on Thursday - MarketBeat
What makes Treace Medical Concepts Inc. stock price move sharplyMaximize your portfolio’s earning power - Jammu Links News
What institutional investors are buying Treace Medical Concepts Inc. stockTremendous wealth creation - Jammu Links News
Is Treace Medical Concepts Inc. stock overvalued or undervaluedGet expert analysis on top stock picks - Jammu Links News
Is it the right time to buy Treace Medical Concepts Inc. stockUnlock exclusive stock market insights - Jammu Links News
Treace Medical Concepts Inc. Stock Analysis and ForecastInvest smarter with expert stock recommendations - Jammu Links News
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Given Average Rating of “Hold” by Brokerages - Defense World
What are Treace Medical Concepts Inc. company’s key revenue driversValue Investing Entry Points With Proven Results - Jammu Links News
Treace Medical Concepts (TMCI) to Release Quarterly Earnings on Thursday - Defense World
Why Treace Medical Concepts Inc. stock attracts strong analyst attentionAI Powered High Return Stock Calls Dominate Watchlists - beatles.ru
Historical volatility pattern of Treace Medical Concepts Inc. visualizedFree Trend Analysis for Safer Trades - Newser
Risk vs reward if holding onto Treace Medical Concepts Inc.Free Reversal Alert Based on RSI Indicator - Newser
Treace Medical Concepts Inc. Tests 50 Day MA After Sharp DeclineRisk Managed Intraday Trade Alerts Increase in Volume - metal.it
트리스 메디컬 컨셉트 (TMCI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
트리스 메디컬 컨셉트 주식 (TMCI) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Scanlan Sean F. | Chief Innovation Officer |
Mar 17 '25 |
Option Exercise |
1.05 |
50,000 |
52,500 |
414,081 |
| Scanlan Sean F. | Chief Innovation Officer |
Mar 17 '25 |
Sale |
7.97 |
50,000 |
398,460 |
364,081 |
0.27%
1.64%
자본화:
|
볼륨(24시간):